Literature DB >> 33425744

Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI.

Yue Hu1, Yue Chen1, Jie Wang1, Jin Juan Kang1, Dan Dan Shen1, Zhong Zheng Jia1.   

Abstract

OBJECTIVES: To investigate whether glioma isocitrate dehydrogenase (IDH) 1 mutation and vascular endothelial growth factor (VEGF) expression can be estimated by histogram analysis of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
METHODS: Chinese Glioma Genome Atlas (CGGA) database was wined for differential expression of VEGF in gliomas with different IDH genotypes. The VEGF expression and IDH1 genotypes of 56 glioma samples in our hospital were assessed by immunohistochemistry. Preoperative DCE-MRI data of glioma samples were reviewed. Regions of interest (ROIs) covering tumor parenchyma were delineated. Histogram parameters of volume transfer constant (Ktrans ) and volume of extravascular extracellular space per unit volume of tissue (Ve ) derived from DCE-MRI were obtained. Histogram parameters of Ktrans , Ve and VEGF expression of IDH1 mutant type (IDH1mut ) gliomas were compared with the IDH1 wildtype (IDH1wt ) gliomas. Receiver operating characteristic (ROC) curve analysis was performed to differentiate IDH1mut from IDH1wt gliomas. The correlation coefficients were determined between histogram parameters of Ktrans , Ve and VEGF expression in gliomas.
RESULTS: In CGGA database, VEGF expression in IDHmut gliomas was lower as compared to wildtype counterpart. The immunohistochemistry of glioma samples in our hospital also confirmed the results. Comparisons demonstrated statistically significant differences in histogram parameters of Ktrans and Ve [mean, standard deviation (SD), 50th, 75th, 90th. and 95th percentile] between IDH1mut and IDH1wt gliomas (P < 0.05, respectively). ROC curve analysis revealed that 50th percentile of Ktrans (0.019 min-1) and Ve (0.039) provided the perfect combination of sensitivity and specificity in differentiating gliomas with IDH1mut from IDH1wt . Irrespective of IDH1 mutation, histogram parameters of Ktrans and Ve were correlated with VEGF expression in gliomas (P < 0.05, respectively).
CONCLUSIONS: VEGF expression is significantly lower in IDH1mut gliomas as compared to the wildtype counterpart, and it is non-invasively predictable with histogram analysis of DCE-MRI.
Copyright © 2020 Hu, Chen, Wang, Kang, Shen and Jia.

Entities:  

Keywords:  glioma; histogram; isocitrate dehydrogenase; magnetic resonance imaging; vascular endothelial growth factor

Year:  2020        PMID: 33425744      PMCID: PMC7793903          DOI: 10.3389/fonc.2020.593102

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  33 in total

1.  The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Zhong Zheng Jia; Hong Mei Gu; Xue Jun Zhou; Jin Long Shi; Min Da Li; Guo Feng Zhou; Xian Hua Wu
Journal:  Eur J Radiol       Date:  2015-06-05       Impact factor: 3.528

2.  Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.

Authors:  Cornelia Brendle; Johann-Martin Hempel; Jens Schittenhelm; Marco Skardelly; Ghazaleh Tabatabai; Benjamin Bender; Ulrike Ernemann; Uwe Klose
Journal:  Clin Neuroradiol       Date:  2017-05-09       Impact factor: 3.649

3.  Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Authors:  Christian Hartmann; Bettina Hentschel; Wolfgang Wick; David Capper; Jörg Felsberg; Matthias Simon; Manfred Westphal; Gabriele Schackert; Richard Meyermann; Torsten Pietsch; Guido Reifenberger; Michael Weller; Markus Loeffler; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2010-11-19       Impact factor: 17.088

Review 4.  Angiogenesis in cancer and other diseases.

Authors:  P Carmeliet; R K Jain
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

5.  Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours.

Authors:  Chao Sun; Yuanlin Zhao; Jiankuan Shi; Jin Zhang; Yuan Yuan; Yu Gu; Feng Zhang; Xing Gao; Chao Wang; Yingmei Wang; Zhe Wang; Peizhen Hu; Junhui Qin; Liming Xiao; Ting Chang; Liang Wang; Yibin Xi; Hong Yin; Huangtao Chen; Lijun Zhang; Guang Cheng; Jiaji Lin; MingMing Zhang; Zhuyi Li; Jing Ye
Journal:  J Neurooncol       Date:  2019-04-19       Impact factor: 4.130

6.  Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma.

Authors:  Mohammad Haris; Nuzhat Husain; Anup Singh; Mazhar Husain; Savita Srivastava; Chhitiz Srivastava; Sanjay Behari; Ram Kishore S Rathore; Sona Saksena; Rakesh Kumar Gupta
Journal:  J Comput Assist Tomogr       Date:  2008 Nov-Dec       Impact factor: 1.826

7.  Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.

Authors:  Teri N Kreisl; Lyndon Kim; Kraig Moore; Paul Duic; Cheryl Royce; Irene Stroud; Nancy Garren; Megan Mackey; John A Butman; Kevin Camphausen; John Park; Paul S Albert; Howard A Fine
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

8.  IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme.

Authors:  Jiří Polívka; Martin Pešta; Pavel Pitule; Ondřej Hes; Luboš Holubec; Jiří Polívka; Tereza Kubíková; Zbyněk Tonar
Journal:  Oncotarget       Date:  2018-02-20

9.  The prognostic value of [123I]-vascular endothelial growth factor ([123I]-VEGF) in glioma.

Authors:  Eva Rainer; Hao Wang; Tatjana Traub-Weidinger; Georg Widhalm; Barbara Fueger; Jingling Chang; Zhaohui Zhu; Christine Marosi; Alexander Haug; Marcus Hacker; Shuren Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-30       Impact factor: 9.236

10.  Prediction of IDH Status Through MRI Features and Enlightened Reflection on the Delineation of Target Volume in Low-Grade Gliomas.

Authors:  Haixia Ding; Yong Huang; Zhiqiang Li; Sirui Li; Qiongrong Chen; Conghua Xie; Yahua Zhong
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
View more
  3 in total

1.  Predicting T and N Staging of Resectable Gastric Cancer According to Whole Tumor Histogram Analysis About a Non-Cartesian k-Space Acquisition DCE-MRI: A Feasibility Study.

Authors:  Liangliang Yan; Jinrong Qu; Jing Li; Hongkai Zhang; Yanan Lu; Jianbo Gao
Journal:  Cancer Manag Res       Date:  2021-10-18       Impact factor: 3.989

2.  Association Between DCE-MRI Perfusion Histogram Parameters and EGFR and VEGF Expressions in Different Lauren Classifications of Advanced Gastric Cancer.

Authors:  Zhiheng Li; Zhenhua Zhao; Chuchu Wang; Dandan Wang; Haijia Mao; Fang Liu; Ye Yang; Feng Tao; Zengxin Lu
Journal:  Pathol Oncol Res       Date:  2022-01-06       Impact factor: 3.201

3.  Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.

Authors:  Yongsheng Zhang; Zhiping Li; Chen Gao; Jianliang Shen; Mingtao Chen; Yufeng Liu; Zhijian Cao; Peipei Pang; Feng Cui; Maosheng Xu
Journal:  Cancer Med       Date:  2021-06-12       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.